Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Aeroflot's passenger traffic in the first half increased by 21%

7/11/24 AFLT

APRI disclosed preliminary IPO parameters

7/11/24 APRI

VK consolidated the developer of Many Apps

7/11/24 VKCO

Etalon Group's sales in the first half increased 2-fold

7/11/24 ETLN

UWC eported for 3 months of 2024 under RAS

7/10/24 UWGN

MTS completed the buyback of shares from non-residents

7/10/24 MTSS

Rosdorbank announced FPO price range

7/10/24 RDRB

Artgen has received authorization to conduct QI of influenza and coronavirus vaccine

7/10/24 ABIO

Henderson's revenue in the first half of the year grew by 31%

7/10/24 HNFG

Samolet sales in the 1st half of the year increased by 42%

7/10/24 SMLT